PRL-3 activates mTORC1 in Cancer Progression
暂无分享,去创建一个
Han-Ming Shen | Jung Eun Park | Q. Zeng | J. Park | Han-Ming Shen | Zu Ye | A. Q. Al-Aidaroos | H. Yuen | S. Zhang | Abhishek Gupta | Y. Lin | Qi Zeng | Hiu Fung Yuen | Zu Ye | Abdul Qader Omer Al-aidaroos | Shu Dong Zhang | Abhishek Gupta | Youbin Lin | A. Q. Al-Aidaroos | Hiu-fung. Yuen
[1] Mu Wang,et al. Phosphatase of Regenerating Liver 3 (PRL3) Provokes a Tyrosine Phosphoproteome to Drive Prometastatic Signal Transduction* , 2013, Molecular & Cellular Proteomics.
[2] Q. Zeng,et al. Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells. , 2013, The Journal of clinical investigation.
[3] K. Guan,et al. Amino acid signalling upstream of mTOR , 2013, Nature Reviews Molecular Cell Biology.
[4] C. Pallen,et al. PRL PTPs: mediators and markers of cancer progression , 2008, Cancer and Metastasis Reviews.
[5] Chang Hwa Jung,et al. mTOR regulation of autophagy , 2010, FEBS letters.
[6] J. Li,et al. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. , 2010, Cancer cell.
[7] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[8] G. Homanics,et al. Protein-tyrosine Phosphatase 4A3 (PTP4A3) Promotes Vascular Endothelial Growth Factor Signaling and Enables Endothelial Cell Motility* , 2014, The Journal of Biological Chemistry.
[9] Zhijian Zhao,et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. , 2005, Bioorganic & medicinal chemistry letters.
[10] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[11] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[12] K. Inoki,et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.
[13] Q. Zeng,et al. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. , 2007, Cancer research.
[14] K. Mills,et al. Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia , 2013, EMBO molecular medicine.
[15] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[16] Christine C. Hudson,et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.
[17] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[18] L. Cantley,et al. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.
[19] A. Teleman,et al. Regulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2 , 2014, Cell.
[20] J. Howell,et al. A Novel Hypoxia-inducible Factor-independent Hypoxic Response Regulating Mammalian Target of Rapamycin and Its Targets* , 2003, Journal of Biological Chemistry.
[21] D. Alessi,et al. Regulation of Akt/PKB Ser473 phosphorylation. , 2005, Molecular cell.
[22] Paul Tempst,et al. Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.
[23] Y. Li,et al. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. , 2008, International journal of molecular medicine.
[24] Michael A. Choti,et al. A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.
[25] Xianglin Shi,et al. Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis , 2012, PloS one.
[26] Q. Zeng,et al. Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases , 2005, Clinical Cancer Research.
[27] Robert T. Abraham,et al. Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase* , 2005, Journal of Biological Chemistry.
[28] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[29] Christine C. Hudson,et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. , 2000, Cancer research.
[30] K. Hess,et al. Mechanisms of action of rapamycin in gliomas. , 2005, Neuro-oncology.
[31] Q. Zeng,et al. PRL‐3 phosphatase and cancer metastasis , 2010, Journal of cellular biochemistry.
[32] D. Choi,et al. ERK1/2 is involved in luteal cell autophagy regulation during corpus luteum regression via an mTOR-independent pathway. , 2014, Molecular human reproduction.
[33] L. Cantley,et al. Phosphatidylinositol metabolism and polyoma-mediated transformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[34] X. Bai,et al. Key factors in mTOR regulation , 2009, Cellular and Molecular Life Sciences.
[35] Q. Zeng,et al. Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice , 2012, Oncotarget.
[36] D. Sabatini,et al. Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1 , 2012, Cell.
[37] C. Proud,et al. Regulation of mammalian translation factors by nutrients. , 2002, European journal of biochemistry.
[38] T. Krieg,et al. Identification of activated matrix metalloproteinase‐2 (MMP‐2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography , 2002, The Journal of pathology.
[39] L. Cantley,et al. Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome , 2014, Cell.
[40] T. Roberts,et al. A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[42] C. Shou,et al. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling , 2009, Molecular Cancer.
[43] P. Finan,et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. , 2012, Molecular cell.
[44] A. Gingras,et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.
[45] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[46] J. Blenis,et al. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. , 2011, Trends in biochemical sciences.
[47] Yan Wang,et al. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway. , 2014, Oncology reports.
[48] S. Meloche,et al. Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor , 2004, Journal of Biological Chemistry.
[49] J. Thiery,et al. A role of autophagy in PTP4A3-driven cancer progression , 2014, Autophagy.
[50] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[51] David M Sabatini,et al. Defining the role of mTOR in cancer. , 2007, Cancer cell.
[52] R. Memmott,et al. Akt-dependent and -independent mechanisms of mTOR regulation in cancer. , 2009, Cellular signalling.
[53] B. Bauvois,et al. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. , 2012, Biochimica et biophysica acta.
[54] C. Betz,et al. Where is mTOR and what is it doing there? , 2013, The Journal of cell biology.
[55] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.